Tan Lu, Tang Xiang-Dong
Sleep Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Mar;54(2):246-251. doi: 10.12182/20230360506.
Hypobaric hypoxia in regions of high altitude may increase the risk of having sleep-disordered breathing (SDB). SDB at high altitude mainly refers to the SDB incurred in highlanders and lowlanders at a high altitude. At present, research on SDB at high altitude is mainly focused on these two groups of people. On the one hand, highlanders have SDB at a higher prevalence and greater severity than lowlanders do and highlanders have a prolonged duration of apnea when they travel to low-altitude regions. On the other hand, the severity of SDB increased in lowlanders when they travel to high altitude, represented mainly by an increase in central and hypopnea events. In terms of treatment, a substantial number of studies have shown that medication, including acetazolamide and dexamethasone, and nocturnal oxygen supplementation could improve SDB in lowlanders when they travel to high altitude. However, not much research has been done on the treatment of SDB in highlanders and it has only been reported that nocturnal oxygen supplementation was an available treatment option. Herein, we summarized the latest research findings on SDB at high altitude, providing the basis for further studies about the characteristics and treatments for highlanders with SDB.
高海拔地区的低压缺氧可能会增加睡眠呼吸障碍(SDB)的风险。高海拔地区的SDB主要指高原居民和初到高原的平原居民所发生的SDB。目前,关于高海拔地区SDB的研究主要集中在这两类人群。一方面,高原居民SDB的患病率和严重程度高于平原居民,且高原居民前往低海拔地区时呼吸暂停持续时间会延长。另一方面,平原居民前往高海拔地区时SDB的严重程度会增加,主要表现为中枢性呼吸暂停和低通气事件增多。在治疗方面,大量研究表明,包括乙酰唑胺和地塞米松在内的药物以及夜间吸氧可以改善平原居民前往高海拔地区时的SDB。然而,针对高原居民SDB治疗的研究较少,仅报道夜间吸氧是一种可行的治疗选择。在此,我们总结了高海拔地区SDB的最新研究结果,为进一步研究高原居民SDB的特征和治疗方法提供依据。